Navigation Links
Immucor Announces Fiscal Third Quarter Results
Date:4/6/2009

35,607 32,228 Total current assets 213,892 271,575 Property and equipment - net 40,108 36,426 Total assets 417,543 364,950 Accounts payable 9,220 7,546 Deferred revenue, current portion 10,748 11,146 Total current liabilities 44,125 41,019 Deferred revenue, long-term portion 12,428 13,010 Other liabilities 3,418 3,225 Shareholders' equity 357,572 307,696 IMMUCOR, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, in thousands) Nine Months Ended February 28, February 29, 2009 2008 OPERATING ACTIVITIES: Net income $56,751 $53,180 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 9,582 6,182 Share-based compensation expense 3,749 3,041 Deferred income taxes 1,453 (3,038) Excess tax benefit from share-based compensation (4,347) (6,629) Other 1,135 769 Changes in operating assets and liabilities, net of effects from acquired companies (14,290) 589 Cash provided by operating activities 54,033 54,094 INVESTING ACTIVITIES:
'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Immucor Announces New Vice President, Operations
2. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
3. Immucor Closes BioArray Acquisition
4. Immucor Schedules Fiscal 2009 Guidance Call
5. Immucor Responding to FDA Warning Letter
6. Immucor Announces Record Fiscal Third Quarter Results
7. Immucor Schedules Third Quarter Earnings Release and Conference Call
8. Immucor, Inc. Adds Director to Board
9. Immucor Announces Update to Second Quarter Conference Call Number
10. Immucor, Inc. Appoints New Chief Financial Officer
11. Immucor Announces Record Fiscal First Quarter Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... A revised version of a surgical procedure to treat ... more than 90 percent of the time in patients ... the MGH Division of Plastic and Reconstructive Surgery report ... the non-endoscopic procedure all of whom had headaches ... symptom relief a year later. The team,s paper ...
(Date:7/28/2014)... 28, 2014 Cape Regional Medical ... Exchange technology solution in an effort to ... support collaboration with their New Jersey health information ... center located in New Jersey, serves the local ... a variety of inpatient and outpatient services. With ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) -- Endurance runners are ... an undetected heart condition, according to a new study. ... participating in events in warm climates are actually 10 ... stroke. Yet, the less common sudden death of a ... problems, such as an irregular heartbeat, often gets a ...
(Date:7/28/2014)... 2014 The Oakwood Foundation celebrated a ... Songe and Associates, PC that will benefit each community ... come. , The HBWS group is among the ... $2.5 million in donations. Through their latest gift, they ... Oakwood Women’s Healthcare Classic for the next 6 years; ...
(Date:7/28/2014)... Stimulating one of two dopamine-producing regions in the brain ... either isoflurane or propofol. In the August issue ... (MGH) report that rats anesthetized with continuous doses of ... stand up in response to electrical stimulation delivered to ... other major dopamine-releasing area, the substantia nigra, did not ...
Breaking Medicine News(10 mins):Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2Health News:Stimulation of brain region restores consciousness to animals under general anesthesia 2
... To Conduct Conference Call Today at 11am ET - SOMERSET, ... TSTF ), a national provider of healthcare and administrative ... quarter ended March 31, 2009. TeamStaff,s operating revenues for the ... compared to $16.1 million in the comparable quarter last year. ...
... Recurring Revenues Climb 84%; Free Cash Flow ... Med Technologies(R), Inc. ("Global Med" or the ... healthcare information technology company, today reported profitability ... growth for the first quarter ended March ...
... BioMarin,s Efforts to Expand Treatment Options for Patients with ... BMRN ) announced today that it has ... for Rare Disorders (NORD), an organization dedicated to improving ... was presented on May 14 at NORD,s annual "Partners ...
... help control anxiety, experts say, , , FRIDAY, May 15 (HealthDay ... isn,t something associated with heights, a job interview or getting ... of worry and tension that affects twice as many women ... eroding their quality of life. , But a new study ...
... study shows CMV raises risk of hypertension, hardening of arteries ... infection that most adults harbor could be a cause of ... cytomegalovirus (CMV) were more likely to develop not only high ... atherosclerosis, according to a report in the May 15 issue ...
... The following news tips are based on abstracts or posters ... Society of Clinical Oncology (ASCO) in Orlando, Florida, May 29 ... 8 a.m. to noon on Monday, June 1, 2009, Antiparasitic ... , Seth J. Orlow, M.D., Ph.D., the Samuel Weinberg ...
Cached Medicine News:Health News:TeamStaff Reports Second Quarter Results 2Health News:TeamStaff Reports Second Quarter Results 3Health News:TeamStaff Reports Second Quarter Results 4Health News:TeamStaff Reports Second Quarter Results 5Health News:TeamStaff Reports Second Quarter Results 6Health News:TeamStaff Reports Second Quarter Results 7Health News:TeamStaff Reports Second Quarter Results 8Health News:TeamStaff Reports Second Quarter Results 9Health News:TeamStaff Reports Second Quarter Results 10Health News:TeamStaff Reports Second Quarter Results 11Health News:TeamStaff Reports Second Quarter Results 12Health News:TeamStaff Reports Second Quarter Results 13Health News:TeamStaff Reports Second Quarter Results 14Health News:TeamStaff Reports Second Quarter Results 15Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 2Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 3Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 4Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 5Health News:Global Med Technologies(R), Inc. Reports Profitability, Record Operating Income and 10th Consecutive Quarter of Record Revenue Growth 6Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 2Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 3Health News:BioMarin Receives 2009 Corporate Award for the Development of Kuvan 4Health News:Fear Response May Stem From Protein in Brain 2Health News:Viral Infection Might Trigger High Blood Pressure 2Health News:Viral Infection Might Trigger High Blood Pressure 3Health News:NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 45th Annual Meeting of ASCO 4
(Date:7/28/2014)... 28, 2014  TNI BioTech, Inc. (OTCQB: TNIB) ... on the development, marketing and distribution of opioid-related ... proxy materials with the Securities and Exchange Commission ... Shareholders to be held on Thursday, September 4, ... record date for determining those shareholders eligible to ...
(Date:7/28/2014)... , 28 luglio 2014 ResMed (NYSE: ... di prodotti per la cura dei disturbi respiratori del ... ha avuto un,ingiunzione permanente in Germania contro il produttore ... proibisce la vendita di apparecchiature da indossare in testa, ... e le maschere 220. La sentenza della Corte Regionale ...
(Date:7/28/2014)... 28, 2014  ResMed (NYSE: RMD ), ... treatment of sleep-disordered breathing and other chronic respiratory conditions, ... against Taiwanese medical device manufacturer APEX Medical ... APEX WiZARD 210 and 220 masks.  The judgment was ... Munich , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... BETHESDA, Md., Dec. 19, 2011 /PRNewswire-Asia/ -- Chindex International, ... care company providing health care services in China through ... private primary care hospitals and affiliated ambulatory clinics, today ... Hospital ("TJU"), one of the latest development projects of ...
...   , First once-daily, fixed-dose preventative treatment ... heartbeat) at risk of the devastating consequences of stroke ... solution for the treatment of deep vein thrombosis (DVT) ... is now approved in the UK for the prevention ...
Cached Medicine Technology:Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 2Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 3Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 2Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 3Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 5Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 6
Transcranial vascular DWL doppler....
Transcranil vascular DWL doppler....
... is a powerful automated system capable of ... from 6 user-programmable test protocols to begin ... Any tests not included in the comprehensive ... handled using the Doppler, PVR and PPG ...
The CD Horizon M10 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
Medicine Products: